Researchers from the University of Texas Medical Branch and Texas Southern University have been awarded a $1 million grant from the National Institutes of Health to use human-centered artificial intelligence to tackle the social and cultural barriers that hinder timely cancer diagnoses and effective treatments in the United States.

Although hospitals are required by law to publicly post prices for their services, it remains difficult for the public to get reliable information on what those services will cost. That’s the overall finding of a paper published Sept. 18 in in the Journal of the American Medical Association: Internal Medicine based on research out of the University of Texas Medical Branch.

The $2 million grant supports a groundbreaking study aimed at addressing firearm injury and violence among adolescents and young adults.

Some people who have Alzheimer’s disease pathology never get dementia because they have a protective biological mechanism working in their favor, a new study suggests.

The University of Texas Medical Branch welcomed some new staff members at the Angleton Danbury campus this week: two nearly life-sized robots programmed to support the human staff and free up nurses from certain tasks to allow them more time to spend with patients.

Imagine if one test could tell you if you were protected from the latest COVID-19 variant. A partnership between state-of-the-art robotics and cutting-edge medical research will allow doctors at the University of Texas Medical Branch (UTMB) to give their patients more personalized and useful information.

The University of Texas Medical Branch School of Nursing came in 10th in the country in the U.S. News & World Report 2023 Best Online Master’s in Nursing Programs rankings released today.

UTMB has been awarded an agreement up to nearly $25 million from the U.S. Department of Defense’s (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the U.S. Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA) (within the Administration for Strategic Preparedness and Response (ASPR)), for their efforts in the collaborative development of vaccines to protect against infection by Ebola (EBOV), Sudan (SUDV), Marburg (MARV), and Lassa (LASV) viruses. This project award was executed via Other Transaction Authority (OTA) to UTMB through the Medical CBRN Defense Consortium (MCDC).

With a $3.5 million grant from the National Institute of Mental Health, University of Texas Medical Branch researchers will study the short- and long-term impact of the COVID-19 pandemic on adolescents’ mental, behavioral and social health.

In a new study, researchers at the University of Texas Medical Branch show that a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever, provides rapid protection against the deadly pathogen.